System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Giuseppe Ambrosio is an expert in Cardiology at Ospedale Santa Maria della Misericordia di Udine (Italy). As of October 2026, ScienceLeadR ranks Giuseppe Ambrosio in the top 1% of experts worldwide for Heart Failure and Myocardial Ischemia. Giuseppe Ambrosio has authored 600 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 1 of them ongoing. SLR score: 1,932 (community average: 125). How the SLR is computed.

LeadR Profile

Giuseppe Ambrosio Ospedale Santa Maria della Misericordia di Udine Italy
1 932 ScienceLeadR Reputation 1932

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Internal Medicine - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1990 - 2026
Source: PubMed

University of Perugia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 600

Citations

Citations: 33 070 1st author: 46 Last author: 148 Unique author: 4

Main journals

Int J Cardiol 40
Eur Heart J 37
G Ital Cardiol (Rome) 22
Eur J Heart Fail 19
J Am Coll Cardiol 17

Best Journals

N Engl J Med 10
Eur Heart J 5
Lancet 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement.
PMID 42817848 — kidney diseases, heart failure, heart, kidney, therapeutics		Eur J Heart Fail20260
Inflammation and iron metabolism dysregulation as hallmarks of COVID-19 severity.
PMID 42707311 — cells, hepcidins, blood, serum, transferrin, covid-19, immune system diseases, ferritins		Front Immunol20260
Bidirectional impact between cardiovascular comorbidities and heart failure: an updated position paper from the Italian society of cardiology (SIC) working group on heart failure.
PMID 42669762 — comorbidity, heart failure, heart, phenotype, arteries, cardiology, peripheral arterial disease, therapeutics		Heart Fail Rev20260
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
PMID 42670965 — safety, hemorrhage, ischemic stroke, stroke, myocardial infarction, acute coronary syndrome, therapeutics		N Engl J Med Top journal20261
Applicability of ischemic heart disease clinical practice guidelines in low- and middle-income countries.
PMID 42386047 — myocardial ischemia, heart diseases, heart, income, cardiology		Int J Cardiol20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 13
N/A 4
Phase 4 1

By status:

Completed 14
Terminated 2
Active not recruiting 1
Unknown 1

By type:

Interventional 17
Observational 1

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 1
multicentricup10 12

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Italian Digital Primary Cardiovascular Prevention Study
NCT05339841 — diabetes mellitus, hypertension, life style, algorithms, mobile applications, risk factors, primary prevention, empowerment, hypercholesterolemia, digital health		N/AActive not recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS